Infrastructure protection and survivability
Infrastructures, such as buildings, protective structures, industrial complexes, tunnels, harbours and pipelines, are a vital part of modern society, all of which are extremely vulnerable to the effects of an explosion. And while an explosion might be unlikely, realistically it cannot be ruled out and the risks should therefore be taken seriously.
An explosion can occur during a military operation, be the result of an accident, or caused deliberately by a terrorist attack. TNO offers clients a broad range of products and services in relation to explosions and protection of infrastructure, such as assessments and advice on countermeasures.
Secure infrastructure: Serving a broad client base
TNO serves a broad client base ranging from the Netherlands Ministery of Defence (MoD) and other governmental ministries to commercial businesses and manufacturers, as well as industry associations.
As an independent organisation with extensive and multidisciplinary experience and track record in applied R&D, we are the trusted partner of the military and our NATO partners. We also assist the Ministry of Foreign Affairs in ensuring the safety and security of Dutch embassies abroad.
Expertise in assessments and countermeasures
Our varied customer base is matched by the range of products and services that TNO offers to its clients. It all starts with a threat and scenario assessment. In collaboration with our client we establish the potential threat(s) as well as realistic hypothetical scenarios. Having defined a scenario, we carry out a vulnerability assessment to define the probable effects of an explosion. TNO also conducts risk assessments.
Using accepted methodologies and (proprietary) models, TNO can determine the probability of an identified threat scenario. We can also predict the potential effects and consequences for people, assets and the security of critical infrastructure should an explosion occur.
To minimise the probability and consequences of an explosion, TNO offers valuable insights garnered through our research and development. To this end, we provide advice on the most effective countermeasures that can be deployed.
At the request of the Netherlands Ministry of Defence, for example, we have carried out Quantitative Risk Analyses (QRA) with respect to safety in the transport, transfer and storage of ammunition.
We do this with our specific expertises:
Unique test & evaluation facilities
Our clients benefit from our position as a leading knowledge and R&D institute. We keep up with – and stand at the forefront of – technological developments, derive new models from evolving knowledge, and share insights distilled from experience and expertise. We do this with the help of state-of-the-art facilities. Our teams have access to experimental labs and offer services such as:
We test and qualify components and structures for compliance with the relevant standards.
- We combine our test & evaluation capabilities with know-how on numerical simulations and theoretical expertise to obtain full understanding of the consequences of threats for structures and related occupants. With in-house developed software we are able to compare the consequences of threat scenarios and to advise authorities and industries on how to improve the safety and security of critical infrastructure.
- We provide post-event (forensic) analytics. If an explosion occurs, whether due to accident or attack, we collect data on the structural damage and injuries to persons resulting from the blast to arrive at an assessment of the characteristics of the explosive charge and specific situation.
It is our mission to make an impact by innovating and applying our expertise. The multidisciplinary nature of our research and development work adds unique value in helping our clients address the societal challenges which they face every day.
In2Innovation: Recycling of waste wood
At TNO, we are In2Innovation. In this series, you will meet the TNO employee behind the innovation. What do they do and what impact does their work have on society? Armed with a blue pop filter, Camilla van Wirdum takes us to all corners of the organisation. In this episode, we talk to Jan de Jong, Wood in Construction project leader, about how a CT scanner contributes to reuse of wood.
Favourable business case for solar heat in homes
Solar heat can make an important contribution to increasing the sustainability of our heat supply. Photovoltaic-thermic (PVT) systems on the roof can, in combination with a heat pump, supply homes with heat and hot water. This would make natural gas redundant, thereby decreasing carbon emissions. There are plenty of options, but what about the cost-benefit analysis?
TNO’s view of 2030: Getting a grip on climate change from space
Greenhouse gas emissions in the atmosphere are one of the main contributors to climate change and must therefore be rapidly reduced if we are to meet the 2030 climate targets. TNO is working on new satellite technology that makes it possible to do so. Because the better we identify emissions, the more targeted the action we can take.
TNO helps accelerate drug development through insight
To find the most effective interventions for complex metabolic diseases, we must first understand the dynamics of disease onset and progression. Only then can key targets and optimal therapeutic windows for more effective treatment be defined. We spoke with Anita van den Hoek, Research Scientist for TNO Metabolic Health, about how TNO helps pharmaceutical companies accelerate drug development through better understanding of disease pathways.
TNO proves method for effective pediatric drug development
Safe and effective drug dosing for young children come with their own challenges. Up to the age of 18, a child’s metabolism can change significantly. And in the first two years of life, those ontogenic differences can be rapid and dramatic. TNO published its findings from the first drug disposition (mass balance/metabolite profiling) study to conclusively prove that microtracing with accelerator mass spectrometry (AMS) is an effective way to collect clinical data in these young patients. This AMS technology can also be the key to building up more data on drug interventions in pregnant and lactating mothers.